Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Towards causal inference-based antidepressant selection with brain and blood biomarkers
    Published on 2025-09-05
    11 months ago
  • Progress and opportunity in developmental neurobiology and youth mental health
    Published on 2025-09-05
    11 months ago
  • The Cognitive–Affective Social Processing and Emotion Regulation (CASPER) model
    Published on 2025-09-04
    11 months ago
  • Role of β-Arrestin 2 in the antinociceptive and side effect profile of morphine and the novel mu opioid receptor agonists, kurkinorin and kurkinol
    Published on 2025-09-03
    11 months ago
  • Innovation with rigor in personalized medicine: back to the basics
    Published on 2025-09-03
    11 months ago
  • Lasting effects of oral contraceptives on fear responses to a safe context
    Published on 2025-08-30
    11 months ago
  • Considerations for conducting developmental neuroimaging research on mental health topics
    Published on 2025-08-30
    11 months ago
« Previous 1 … 41 42 43 44 45 … 143 Next »
Journal of Psychopharmacology
  • Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat
    Published on 2024-09-28
    2 years ago
  • Aspirin may be more suitable for patients with major depression: Evidence from two-sample Mendelian randomization analysis
    Published on 2024-09-25
    2 years ago
  • Optimizing the individual dosing of paroxetine in major depressive disorder with therapeutic drug monitoring
    Published on 2024-09-25
    2 years ago
  • Serotonin release by parachloroamphetamine in rats with high and low sociability: High prefrontal release capacity in sociable females
    Published on 2024-09-25
    2 years ago
  • Clinical effects of CYP2D6 phenoconversion in patients with psychosis
    Published on 2024-09-23
    2 years ago
  • Influence of panic disorder and paroxetine on brain functional hubs in drug-free patients
    Published on 2024-09-23
    2 years ago
  • Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample
    Published on 2024-09-23
    2 years ago
« Previous 1 … 41 42 43 44 45 … 150 Next »
European Neuropsychopharmacology
  • Response to ensuring safety in cannabinoid prescriptions: A call for critical assessment
    Published on 2024-09-06
    2 years ago
  • Clinical research in pediatric autism
    Published on 2024-09-06
    2 years ago
  • From erectile dysfunction to dementia: A new role for sildenafil
    Published on 2024-09-06
    2 years ago
  • The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis
    Published on 2024-09-06
    2 years ago
  • Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research
    Published on 2024-09-06
    2 years ago
  • The Transdiagnostic Global Impression – Psychopathology scale (TGI-P): Initial development of a novel transdiagnostic tool for assessing, tracking, and visualising psychiatric symptom severity in everyday practice
    Published on 2024-09-06
    2 years ago
  • The gut-microbiome in adult Attention-deficit/hyperactivity disorder – A Meta-analysis
    Published on 2024-09-06
    2 years ago
« Previous 1 … 41 42 43 44 45 … 168 Next »

   Pharma Pub